LIFE Annual CFO
-$33.22 M
+$8.66 M+20.69%
31 December 2023
Summary:
As of February 4, 2025, LIFE annual cash flow from operations is -$33.22 million, with the most recent change of +$8.66 million (+20.69%) on December 31, 2023. During the last 3 years, it has fallen by -$17.92 million (-117.12%).LIFE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE Quarterly CFO
-$22.38 M
-$11.32 M-102.31%
31 March 2024
Summary:
As of February 4, 2025, LIFE quarterly cash flow from operations is -$22.38 million, with the most recent change of -$11.32 million (-102.31%) on March 31, 2024. Over the past year, it has dropped by -$21.79 million (-3693.22%).LIFE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE TTM CFO
-$55.01 M
-$21.79 M-65.59%
31 March 2024
Summary:
As of February 4, 2025, LIFE TTM cash flow from operations is -$55.01 million, with the most recent change of -$21.79 million (-65.59%) on March 31, 2024. Over the past year, it has dropped by -$22.65 million (-70.01%).LIFE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | -3693.2% | -70.0% |
| 3 y3 years | -117.1% | -145.5% | -41.8% |
| 5 y5 years | -7.0% | -271.6% | -174.9% |
LIFE Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +117.1% | -1187.5% | +767.0% |
ATyr Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$22.38 M(+102.3%) | -$55.01 M(+65.6%) |
| Dec 2023 | -$33.22 M(-20.7%) | -$11.06 M(+15.7%) | -$33.22 M(+2.1%) |
| Sept 2023 | - | -$9.56 M(-20.4%) | -$32.53 M(-7.7%) |
| June 2023 | - | -$12.01 M(+1935.6%) | -$35.25 M(+8.9%) |
| Mar 2023 | - | -$590.00 K(-94.3%) | -$32.36 M(-22.7%) |
| Dec 2022 | -$41.89 M(+26.6%) | -$10.37 M(-15.6%) | -$41.89 M(+5.8%) |
| Sept 2022 | - | -$12.28 M(+34.7%) | -$39.60 M(+2.1%) |
| June 2022 | - | -$9.12 M(-9.9%) | -$38.79 M(+3.8%) |
| Mar 2022 | - | -$10.12 M(+25.1%) | -$37.37 M(+13.0%) |
| Dec 2021 | -$33.08 M(+116.2%) | -$8.09 M(-29.5%) | -$33.08 M(+8.8%) |
| Sept 2021 | - | -$11.47 M(+49.1%) | -$30.39 M(+24.2%) |
| June 2021 | - | -$7.69 M(+32.0%) | -$24.48 M(+5.6%) |
| Mar 2021 | - | -$5.83 M(+7.9%) | -$23.19 M(+51.5%) |
| Dec 2020 | -$15.30 M(-23.5%) | -$5.40 M(-2.8%) | -$15.30 M(+3.3%) |
| Sept 2020 | - | -$5.55 M(-13.2%) | -$14.82 M(+9.6%) |
| June 2020 | - | -$6.40 M(-411.1%) | -$13.51 M(+13.3%) |
| Mar 2020 | - | $2.06 M(-141.9%) | -$11.93 M(-40.4%) |
| Dec 2019 | -$20.01 M(-35.6%) | -$4.92 M(+15.6%) | -$20.01 M(+0.4%) |
| Sept 2019 | - | -$4.25 M(-11.8%) | -$19.94 M(-10.0%) |
| June 2019 | - | -$4.82 M(-20.0%) | -$22.14 M(-16.5%) |
| Mar 2019 | - | -$6.02 M(+24.5%) | -$26.51 M(-14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$31.06 M(-26.7%) | -$4.84 M(-25.1%) | -$31.06 M(-15.0%) |
| Sept 2018 | - | -$6.46 M(-29.7%) | -$36.53 M(-6.2%) |
| June 2018 | - | -$9.19 M(-13.1%) | -$38.96 M(-0.2%) |
| Mar 2018 | - | -$10.58 M(+2.6%) | -$39.05 M(-7.8%) |
| Dec 2017 | -$42.36 M(-19.9%) | -$10.31 M(+15.9%) | -$42.36 M(-3.2%) |
| Sept 2017 | - | -$8.89 M(-4.1%) | -$43.75 M(-11.7%) |
| June 2017 | - | -$9.28 M(-33.2%) | -$49.55 M(-8.7%) |
| Mar 2017 | - | -$13.89 M(+18.8%) | -$54.26 M(+2.6%) |
| Dec 2016 | -$52.86 M(+43.7%) | -$11.70 M(-20.4%) | -$52.86 M(+3.6%) |
| Sept 2016 | - | -$14.69 M(+5.0%) | -$51.00 M(+11.4%) |
| June 2016 | - | -$13.99 M(+12.0%) | -$45.78 M(+6.5%) |
| Mar 2016 | - | -$12.49 M(+27.0%) | -$43.00 M(+16.9%) |
| Dec 2015 | -$36.80 M(+61.2%) | -$9.84 M(+3.9%) | -$36.80 M(+12.3%) |
| Sept 2015 | - | -$9.47 M(-15.5%) | -$32.76 M(+12.7%) |
| June 2015 | - | -$11.21 M(+78.3%) | -$29.07 M(+27.7%) |
| Mar 2015 | - | -$6.29 M(+8.4%) | -$22.77 M(-0.3%) |
| Dec 2014 | -$22.82 M(+31.8%) | -$5.80 M(+0.4%) | -$22.82 M(+34.1%) |
| Sept 2014 | - | -$5.78 M(+17.9%) | -$17.02 M(+51.4%) |
| June 2014 | - | -$4.90 M(-22.8%) | -$11.24 M(+77.2%) |
| Mar 2014 | - | -$6.34 M | -$6.34 M |
| Dec 2013 | -$17.31 M | - | - |
FAQ
- What is aTyr Pharma annual cash flow from operations?
- What is the all time high annual CFO for aTyr Pharma?
- What is aTyr Pharma annual CFO year-on-year change?
- What is aTyr Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for aTyr Pharma?
- What is aTyr Pharma quarterly CFO year-on-year change?
- What is aTyr Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for aTyr Pharma?
- What is aTyr Pharma TTM CFO year-on-year change?
What is aTyr Pharma annual cash flow from operations?
The current annual CFO of LIFE is -$33.22 M
What is the all time high annual CFO for aTyr Pharma?
aTyr Pharma all-time high annual cash flow from operations is -$15.30 M
What is aTyr Pharma annual CFO year-on-year change?
Over the past year, LIFE annual cash flow from operations has changed by +$8.66 M (+20.69%)
What is aTyr Pharma quarterly cash flow from operations?
The current quarterly CFO of LIFE is -$22.38 M
What is the all time high quarterly CFO for aTyr Pharma?
aTyr Pharma all-time high quarterly cash flow from operations is $2.06 M
What is aTyr Pharma quarterly CFO year-on-year change?
Over the past year, LIFE quarterly cash flow from operations has changed by -$21.79 M (-3693.22%)
What is aTyr Pharma TTM cash flow from operations?
The current TTM CFO of LIFE is -$55.01 M
What is the all time high TTM CFO for aTyr Pharma?
aTyr Pharma all-time high TTM cash flow from operations is -$6.34 M
What is aTyr Pharma TTM CFO year-on-year change?
Over the past year, LIFE TTM cash flow from operations has changed by -$22.65 M (-70.01%)